Cartherics selected for oral presentation at SITC 2026 for CTH-401, a novel off-the-shelf ovarian cancer cell therapy
MELBOURNE, VICTORIA, AUSTRALIA, November 4, 2026 /EINPresswire.com/ -- Cartherics Pty Ltd (“Cartherics” or “Company”), a biotechnology company developing off-the-shelf immune cell therapies is pleased to announce that it will present an update on …